(Q33253538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

transitional cell carcinoma

28 December 2019

main subject

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Andrea Staack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Steffen Badendieck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dietmar Schnorr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stefan A Loening

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

10 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma

28 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Regulation of matrix biology by matrix metalloproteinases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Metastasis markers in bladder cancer: a review of the literature and clinical considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

TIMPs as multifacial proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Tumour invasion and matrix metalloproteinases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Matrix metalloproteinases and bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Urinary markers of malignancy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Current concepts in biomarker technology for bladder cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

21 June 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Membrane proteases: roles in tissue remodeling and tumour invasion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

mROC: a computer program for combining tumour markers in predicting disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560390

Complement Factor H as a Marker for Detection of Bladder Cancer

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-6-19

Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas

21 January 2018

1 reference

12 December 2020

Simple solution to a common statistical problem: interpreting multiple tests

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family

1 reference

12 December 2020

Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma

1 reference

12 December 2020

Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood

1 reference

12 December 2020

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

12 December 2020

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma

1 reference

12 December 2020

Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

1 reference

12 December 2020

Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection

1 reference

12 December 2020

Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes

1 reference

12 December 2020

Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer

1 reference

12 December 2020

MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival

1 reference

12 December 2020

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

1 reference

12 December 2020

Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2490-6-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 December 2019

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2490-6-19

9 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16901349%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

16901349

1 reference